DAN:TCM
$1.03
5.295%
Prelude Therapeutics IncorporatedInsider Activity
Last updated: Jun 9, 2025, 3:14 AM ET
Profile
Company Description
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.